Organon & Co. (OGN)
13.78
+0.03
(+0.22%)
USD |
NYSE |
Oct 28, 16:00
13.79
+0.01
(+0.07%)
Pre-Market: 20:00
Organon Market Cap : 3.619B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 3.619B |
| October 27, 2026 | 3.611B |
| October 26, 2026 | 3.608B |
| October 23, 2026 | 3.611B |
| October 22, 2026 | 3.611B |
| October 21, 2026 | 3.611B |
| October 20, 2026 | 3.613B |
| October 19, 2026 | 3.611B |
| October 16, 2026 | 3.613B |
| October 15, 2026 | 3.613B |
| October 14, 2026 | 3.608B |
| October 13, 2026 | 3.616B |
| October 12, 2026 | 3.616B |
| October 09, 2026 | 3.627B |
| October 08, 2026 | 3.611B |
| October 07, 2026 | 3.621B |
| October 06, 2026 | 3.608B |
| October 05, 2026 | 3.598B |
| October 02, 2026 | 3.603B |
| October 01, 2026 | 3.600B |
| September 30, 2026 | 3.598B |
| September 29, 2026 | 3.608B |
| September 28, 2026 | 3.606B |
| September 25, 2026 | 3.606B |
| September 24, 2026 | 3.603B |
| Date | Value |
|---|---|
| September 23, 2026 | 3.606B |
| September 22, 2026 | 3.598B |
| September 21, 2026 | 3.592B |
| September 18, 2026 | 3.592B |
| September 17, 2026 | 3.595B |
| September 16, 2026 | 3.590B |
| September 15, 2026 | 3.587B |
| September 14, 2026 | 3.585B |
| September 11, 2026 | 3.582B |
| September 10, 2026 | 3.579B |
| September 09, 2026 | 3.590B |
| September 08, 2026 | 3.611B |
| September 04, 2026 | 3.619B |
| September 03, 2026 | 3.616B |
| September 02, 2026 | 3.616B |
| September 01, 2026 | 3.613B |
| August 31, 2026 | 3.613B |
| August 28, 2026 | 3.613B |
| August 27, 2026 | 3.613B |
| August 26, 2026 | 3.616B |
| August 25, 2026 | 3.611B |
| August 24, 2026 | 3.611B |
| August 21, 2026 | 3.611B |
| August 20, 2026 | 3.608B |
| August 19, 2026 | 3.606B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viatris, Inc. | 21.68B |
| Pacira Biosciences, Inc. | 1.449B |
| Bristol Myers Squibb Co. | 123.74B |
| Harmony Biosciences Holdings, Inc. | 2.238B |
| ANI Pharmaceuticals, Inc. | 1.647B |
Market Cap Related Metrics
| PE Ratio | 17.65 |
| PS Ratio | 0.5927 |
| Price to Book Value | 3.597 |
| Price to Free Cash Flow | 6.508 |
| Price | 13.78 |
| Earnings Yield | 5.66% |
| Operating PE Ratio | 3.054 |
| Normalized PE Ratio | 9.105 |